Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Opening Session Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Jun
22
Today In Oncology
Aumolertinib Plus Chemotherapy in EGFR-Mutated Advanced NSCLC
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia
AI-Assisted Tumor Volume Response Criteria Outperform Physician Assessments and RECIST Criteria in Pleural Mesothelioma
Metastatic Colorectal Cancer GUCY2C-Targeted CAR T-Cell Therapy
Ga-68–PSMA-11 PET/CT in Diagnosis of Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo